Form D · Other Health Care

IR-Med, Inc.

Rosh Pina, L3 · CIK 0001839133

Offering snapshot reported Apr 26, 2022 · SEC filing

Reported sold
$3.2M
Offering amount: $5M
Investors reported
2
Form D · investor count
Minimum accepted
$50K
Reported outside-investor minimum
First sale
Apr 11, 2022
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 26, 2022Initial$3,200,000No comparison2SEC filing
Jan 12, 2021Initial$2,206,000No comparison11SEC filing
Jan 8, 2021Initial$0No comparison2SEC filing

Offering details

Securities
Equity, Option to acquire
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-443346

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
NoneNone

Source: Form D, filed Apr 26, 2022. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Oded Bashan Director
Ohad Bashan Director
Aharon Binur Executive
Yaniv Cohen Director
Limor Davidson Mund Executive
Yoram Drucker Director
Rom Eliaz Executive
Aharon Klein Director, Executive
David Lazar Director
Sharon Lefkovitz Executive
Sharon Levkoviz Executive
Ron Mayrom Director
Ron Mayron Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:
Z.H.R Industrial Zone
Rosh Pina, L3, 1210002